Books: 'Bone resorption'

1

Felix, Bronner, Farach-Carson Mary C. 1958-, and Rubin Janet, eds. Bone resorption. London: Springer, 2005.

APA, Harvard, Vancouver, ISO, and other styles

2

Bronner, Felix, Mary C. Farach-Carson, and Janet Rubin, eds. Bone Resorption. London: Springer-Verlag, 2005. http://dx.doi.org/10.1007/b136184.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Harvey, Wilson. Prostaglandins in bone resorption. Boca Raton, Fla: CRC Press, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Pierce, Angela Mary. Cellular mechanisms in bone and tooth resorption: Morphological studies in rats and monkeys. Stockholm: Kongl. Carolinska Medico Chirurgiska Institutet, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Brown, R. James. Histological and compositional responses of bone to immobilization and other experimental conditions: Semi-annual report. San Francisco, Calif: Institute of Chemical Biology, University of San Francisco, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Arun, Shanbhag, Rubash Harry E, and Jacobs Joshua J. 1956-, eds. Joint replacement and bone resorption: Pathology, biomaterials, and clinical practice. New York: Taylor & Francis, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Maria, Bijvoet Olav Leonardus, ed. Bisphosphonate on bones. Amsterdam: Elsevier, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Åkesson, Louise. Panoramic radiography in the assessment of the marginal bone level. Malmö: Department of Oral Radiology, Faculty of Odontology, Lund University, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Fleisch, Herbert. Bisphosphonates in bone disease: From the laboratory to the patient. Bern: H. Fleish, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Jonasson, Grethe. Mandibular alveolar bone mass, structure and thickness in relation to skeletal bone density in dentate women. Göteborg: Department of Orthodontics, Faculty of Odontology, The Sahlgrenska Academy at Göteborg University, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Loomer, Peter Michael. The direct effects of Porphyromonas Gingivalis 2561 on bone formation and mineral resorption in vitro. [Toronto: University of Toronto, Faculty of Dentistry], 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Fleisch, Herbert. Bisphosphonates in bone disease: From the laboratory to the patient. 3rd ed. New York: Parthenon Pub. Group, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Fleisch, Herbert. Bisphosphonates in bone disease: From the laboratory to the patient. 2nd ed. New York: Parthenon Pub. Group, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Fleisch, Herbert. Bisphosphonates in bone disease: From the laboratory to the patient. 4th ed. San Diego: Academic Press, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

D, Rubens R., and European Conference on Clinical Oncology (5th : 1989 : London, England), eds. The Management of bone metastases and hypercalcaemia by osteoclast inhibition: An international symposium held during the 5th European Conference on Clinical Oncology (ECCO 5), London, September 1989. Toronto: Hogrefe & Huber, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Congress, European Society for Medical Oncology. Disodium pamidronate (APD) in the treatment of malignancy-related disorders: An international symposium held during the 13th Congress of the European Society for Medical Oncology (ESMO), Lugano, Switzerland, October 1988. Toronto: Hogrefe & Huber, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Peter, Burckhardt, ed. Disodium pamidronate (APD) in the treatment of malignancy-related disorders. Toronto: Huber, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Meyer, James L. I loved a boy: Confessions of a Roman Catholic priest. Royal Oak, Mich: Van Antwerp and Beale Publishers, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Meyer, James L. I loved a boy: Confessions of a Roman Catholic priest. Royal Oak, Mich: Van Antwerp and Beale Publishers, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

Shorey, Seema. Differences in the degree to which osteoclasts from different parts of the skeleton employ cathepsin K and matrix metalloproteinases for bone resorption. Ottawa: National Library of Canada, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

Tai, Victoria. The effects of leukotriene Bb4s on osteoclast formation and osteoclastic bone resorption and the role of osteoblastic cells in these processes. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Mundy, Gregory R. Bone remodeling and its disorders. London: Martin Dunitz, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

Mundy, Gregory R. Bone remodeling and its disorders. London: Martin Dunitz, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

Bronner, Felix, Janet Rubin, and Mary C. Farach-Carson. Bone Resorption. Springer London, Limited, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

Bronner, Felix, Janet Rubin, and Mary C. Farach-Carson. Bone Resorption. Springer London, Limited, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Harvey, Wilson, and Alan Bennett. Prostaglandins in Bone Resorption. CRC Press, 2020. http://dx.doi.org/10.1201/9780429279195.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Harvey, Wilson, and Alan Bennett. Prostaglandins in Bone Resorption. Taylor & Francis Group, 2020.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

Harvey, Wilson, and Alan Bennett. Prostaglandins in Bone Resorption. Taylor & Francis Group, 2020.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

Harvey, Wilson, and Alan Bennett. Prostaglandins in Bone Resorption. Taylor & Francis Group, 2020.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

Harvey, Wilson, and Alan Bennett. Prostaglandins in Bone Resorption. Taylor & Francis Group, 2019.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

31

Harvey, Wilson, and Alan Bennett. Prostaglandins in Bone Resorption. Taylor & Francis Group, 2020.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

Bone resorption, metastasis, and diphosphonates. New York: Raven Press, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

Shanbhag, Arun, Harry E. Rubash, and Joshua J. Jacobs, eds. Joint Replacement and Bone Resorption. CRC Press, 2005. http://dx.doi.org/10.1201/b14138.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Rubash, Harry E., Arun Shanbhag, and Joshua J. Jacobs. Joint Replacement and Bone Resorption. Taylor & Francis Group, 2019.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

OGURA, HIDEAKI. Pharmacological Approach to the Study of the Formation and the Resorption Mechanism of Hard Tissues. MEDICO DENTAL MEDIA INTERNATIONAL, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

Osteoblasts: Morphology, Functions and Clinical Implications. Nova Science Pub Inc, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

Anderson, Paul, Borje Edgar Christopher Nordin, and Howard Arthur Morris. Physiological Basis of Metabolic Bone Disease. Taylor & Francis Group, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

Anderson, Paul, Borje Edgar Christopher Nordin, and Howard Arthur Morris. Physiological Basis of Metabolic Bone Disease. Taylor & Francis Group, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

39

Anderson, Paul, Howard A. Morris, and B. E. Christopher Nordin. Physiological Basis of Metabolic Bone Disease. Taylor & Francis Group, 2017.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

40

Anderson, Paul, Borje Edgar Christopher Nordin, and Howard Arthur Morris. Physiological Basis of Metabolic Bone Disease. Taylor & Francis Group, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

41

Rubash, Harry E., Arun Shanbhag, and Joshua J. Jacobs. Joint Replacement and Bone Resorption: Pathology, Biomaterials and Clinical Practice. Taylor & Francis Group, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

(Editor), Arun Shanbhag, Harry E. Rubash (Editor), and Joshua J. Jacobs (Editor), eds. Joint Replacement and Bone Resorption: Pathology, Biomaterials and Clinical Practice. Informa Healthcare, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

43

Rubash, Harry E., Arun Shanbhag, and Joshua J. Jacobs. Joint Replacement and Bone Resorption: Pathology, Biomaterials and Clinical Practice. Taylor & Francis Group, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

44

Mansfield, Ian David. The synthesis of novel agents which inhibit tumour-stimulated bone resorption. 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

45

The relationship between bone mineral density and selected variables: An epidemiological perspective. 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

Javaid, Kassim. Paget’s disease of bone. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0274.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

Paget’s disease of bone is an uncommon bone disorder with increased bone resorption and disorganized bone formation of woven bone. Its cause is unclear; there is a clear genetic component but additional environmental factors are important, given the reduction in severity and prevalence in the UK. Paget’s disease is usually asymptomatic and detected by an unexplained raised alkaline phosphatase on routine biochemistry. Symptoms include focal bone pain, including headache. Other symptoms include bone deformity and complications such as fracture and nerve conduction. Paget’s disease can sometimes present with immobilization-associated hypercalcaemia or high-output cardiac failure, and rarely can transform to an osteosarcoma. This chapter addresses the clinical features, diagnosis, and management of Paget’s disease of bone.

47

Effects of prostaglandin Eb2s on chick bone rudiments in vitro: Studies on bone resorption and formation. Ottawa: National Library of Canada, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

48

Wordsworth, B. P. Skeletal dysplasias. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0150.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

Bone is metabolically active throughout life and metabolic disturbances may have wide-ranging consequences that are not restricted to altering its mechanics. The study of some genetic bone diseases has already provided remarkable insights into the normal regulation of bone metabolism. Skeletal dysplasias are developmental disorders of the chondro-osseous tissues commonly resulting in short stature, which is often disproportionate. The underlying mutations are often in the structural genes encoding components of the matrix but may also involve growth factors or cell signalling. In contrast, the dysostoses tend to affect single bones or groups of bones, reflecting the transient nature of the many different signalling factors to which they are responsive during development. Abnormalities of bone density (high or low) may be due to primary deficiency of bone matrix synthesis (e.g. osteogenesis imperfecta and hypophosphatasia) but may also reflect an imbalance between bone formation and resorption. This may be caused by abnormalities of bone formation (e.g. hyperostosis/sclerosteosis and osteoporosis pseudoglioma syndrome) or bone resorption (e.g. classic osteopetrosis and fibrous dysplasia).

49

Ralston, Stuart H. Paget’s disease of bone. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0144.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

Paget's disease of bone (PDB) affects up to 1% of people of European origin aged 55 years and above. It is characterized by focal abnormalities of bone remodelling which disrupt normal bone architecture, leading to expansion and reduced mechanical strength of affected bones. This can lead to various complications including deformity, fracture, nerve compression syndromes, and osteoarthritis, although many patients are asymptomatic. Genetic factors play a key role in the pathogenesis of PDB. This seems to be mediated by a combination of rare genetic variants which cause familial forms of the disease and common variants which increase susceptibility to environmental triggers. Environmental factors which have been suggested to predispose to PDB include viral infections, calcium and vitamin D deficiency, and excessive mechanical loading of affected bones. The diagnosis can be made by the characteristic changes seen on radiographs, but isotope bone scans are helpful in defining disease extent. Serum alkaline phosphatase levels can be used as a measure of disease activity. Inhibitors of bone resorption are the mainstay of medical management for PDB and bisphosphonates are regarded as the treatment of choice. Bisphosphonates are highly effective at reducing bone turnover in PDB and have been found to heal osteolytic lesions, and normalize bone histology. Although bisphosphonates can improving bone pain caused by elevated bone turnover, most patients require additional therapy to deal with symptoms associated with disease complications. It is currently unclear whether bisphosphonate therapy is effective at preventing complications of PDB.

50

Ralston, Stuart H. Paget’s disease of bone. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199642489.003.0144_update_001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

Paget’s disease of bone (PDB) affects up to 1% of people of European origin aged 55 years and above. It is characterized by focal abnormalities of bone remodelling which disrupt normal bone architecture, leading to expansion and reduced mechanical strength of affected bones. This can lead to various complications including deformity, fracture, nerve compression syndromes, and osteoarthritis, although many patients are asymptomatic. Genetic factors play a key role in the pathogenesis of PDB. This seems to be mediated by a combination of rare genetic variants which cause familial forms of the disease and common variants which increase susceptibility to environmental triggers. Environmental factors which have been suggested to predispose to PDB include viral infections, calcium and vitamin D deficiency, and excessive mechanical loading of affected bones. The diagnosis can be made by the characteristic changes seen on radiographs, but isotope bone scans are helpful in defining disease extent. Serum alkaline phosphatase levels can be used as a measure of disease activity. Inhibitors of bone resorption are the mainstay of medical management for PDB and bisphosphonates are regarded as the treatment of choice. Bisphosphonates are highly effective at reducing bone turnover in PDB and have been found to heal osteolytic lesions, and normalize bone histology. Although bisphosphonates can improving bone pain caused by elevated bone turnover, most patients require additional therapy to deal with symptoms associated with disease complications. It is currently unclear whether bisphosphonate therapy is effective at preventing complications of PDB.

Books on the topic 'Bone resorption'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles